Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Patient-reported Outcomes across Phase 3 studies of Baricitinib demonstrate Statistically Significant Improvements in Physical Function and Quality of Life Symptoms in Patients with Rheumatoid Arthritis (RA) 2016-06-09 18:45
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs 2016-06-09 18:45
World-class Architects, Designers and Engineers to Unveil the Future of 3D at In(3D)ustry 2016-06-09 10:00
Strategy Analytics: Smart Home Elderly Monitoring Opportunity Is Set to Grow More Than 600% by 2020 2016-06-08 22:08
Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders 2016-06-08 21:02
The Walt Disney Company Announces $3 Million (RMB 20 Million) Donation to Create Play Spaces in Children's Hospitals Across China 2016-06-08 19:08
Active Ager Asia Pays You to Walk for Your Health 2016-06-08 10:00
Innovative Diagnostics Awarded Unprecedented Westgard Sigma Certification in Singapore 2016-06-08 09:00
Retail Healthcare Transforms as Patients Seek Alternative Healthcare Options Driving Growth Opportunities for Traditional and Non-Traditional Care Givers 2016-06-07 21:35
Disruptive Technologies and Emerging Trends Drive Life Science Transformation 2016-06-07 21:05
Results of Clinical and Patient-Reported Outcomes Data for Baricitinib in Patients with Rheumatoid Arthritis to be Presented at Annual European Congress of Rheumatology (EULAR 2016) 2016-06-07 19:00
China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2016 Financial Results 2016-06-07 18:30
New In-Vitro Studies Reinforce Efficacy of BETADINE(R) Skin Cleanser against Viruses that cause Hand Foot & Mouth Disease 2016-06-07 12:33
Takeda to Present New Data at the American Diabetes Association's 76th Scientific Sessions 2016-06-07 01:09
FLT-PET Scan Provides Early Evidence of Response to Arginine Depletion by ADI-PEG 20 in Argininosuccinate Synthetase Deficient Thoracic Tumors 2016-06-07 00:00
Polaris Group Reports Phase III Study Results of ADI-PEG 20 plus Best Supportive Care in Advanced Hepatocellular Carcinoma 2016-06-07 00:00
Novo Nordisk to Present 53 Abstracts at 76th Annual American Diabetes Association Scientific Sessions in New Orleans, LA 2016-06-06 22:03
Finesse SmartFactory(TM) Platform Featured in Alvotech Opening of New Manufacturing and Lab Facility in Iceland 2016-06-06 21:00
SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment 2016-06-06 20:54
International Medical Group Gets Social with its Global Service 2016-06-06 20:46
1 791 792 793 794 795 810